SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-078673
Filing Date
2014-11-10
Accepted
2014-11-10 08:05:23
Documents
3
Period of Report
2014-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-23709_18k.htm 8-K 25052
2 EX-99.1 a14-23709_1ex99d1.htm EX-99.1 132909
3 GRAPHIC g237091mmi001.jpg GRAPHIC 5481
  Complete submission text file 0001104659-14-078673.txt   166809
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 141206624
SIC: 2834 Pharmaceutical Preparations